Dr. Vishangi A. Dave, MD

Dr. Dave practices at Banner Boswell Medical Center in Sun City, Arizona, part of Banner Health.

Dr. Dave's NPI, 1780947028, was assigned on June 21, 2012. Dr. Dave holds Arizona license 56569.

Dr. Dave's primary practice is Banner Boswell Medical Center, at 13632 N 99th Ave, Sun City, AZ 85351 in Maricopa County. The practice phone is (623) 832-4000. Dr. Dave also practices at Banner Boswell Medical Center, 10401 W Thunderbird Blvd, Sun City, AZ 85351.

Dr. Dave's primary practice is Banner Boswell Medical Center in Sun City, Arizona, part of Banner Health. Dr. Dave is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is Banner Cancer Center Specialists LLC. Dmand AI also links Dr. Dave to 2 more hospitals, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dave practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dave's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dave is licensed in Arizona.

CMS data shows 590 Medicare services from Dr. Dave across 4 procedure codes in 2024, for 300 Medicare patients. Medicare paid $61,842 for them.

CMS counts 300 Medicare patients who saw Dr. Dave in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dave's median patient age at 75, with 49% women.

In 2024, Dr. Dave wrote 639 Medicare Part D claims for 170 patients. 70% of them were for generic drugs. CMS names the drug for 421 of them, across 18 drugs with 11 or more claims each, at $845,185 in total drug cost. In 2023, CMS named 545 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Dave for performance year 2024, reported as part of a group. Dr. Dave accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dave as offering telehealth.

Dmand AI links 3 papers to Dr. Dave, published from 2016 to 2017. Dr. Dave's most frequent co-authors are Vivek Kumar, MD, Yiwu Huang, MD and Yiqing Xu, MD, PhD.

Dmand AI links Dr. Dave to 7 clinical trials, 3 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Renal Cell, Hodgkin Disease and Hypopharyngeal Neoplasms. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 13 general payments to Dr. Dave from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 76% of the total. Astellas Pharma US Inc paid the most, $188.